Prelude Therapeutics (PRLD) Assets (2019 - 2026)
Prelude Therapeutics' Assets was $189.36 million in Q2 2026, up 64.8% from $114.92 million a year earlier and up 58.3% from the prior quarter.
Powered by 
Analysis
Prelude Therapeutics (PRLD) Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Assets at Prelude Therapeutics came in at $141.32 million, down 19.5% from FY2024.
- Assets shows a five-year compound annual growth rate of -8.8% (FY2020 to FY2025).
- In earlier years, Assets was $175.52 million in FY2024 (-36.8%), $277.67 million in FY2023 (+25.9%), $220.5 million in FY2022 (-27.7%) and $305.1 million in FY2021 (+36.5%).
- The Q2 2026 figure marks the highest quarterly Assets since Q3 2024.
- Compared with a year earlier, Assets was higher in 1 of the last eight quarters, with an average decline of 21.8%.
- The best year-over-year quarter for Assets over five years was Q2 2026 (growth of 64.8%); the worst was Q3 2025 (a decline of 52.0%).
- Per Business Quant data, PRLD's Assets in the three quarters before Q2 2026 was $119.64 million (Q1 2026), $141.32 million (Q4 2025) and $94.76 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Prelude Therapeutics | 312.03 Mn | -285.27 Mn | - | 189.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 189.36 Mn |
| Mar 31, 2026 | 119.64 Mn |
| Dec 31, 2025 | 141.32 Mn |
| Sep 30, 2025 | 94.76 Mn |
| Jun 30, 2025 | 114.92 Mn |
| Mar 31, 2025 | 141.26 Mn |
| Dec 31, 2024 | 175.52 Mn |
| Sep 30, 2024 | 197.22 Mn |
| Jun 30, 2024 | 224.29 Mn |
| Mar 31, 2024 | 247.11 Mn |
| Dec 31, 2023 | 277.67 Mn |
| Sep 30, 2023 | 258.51 Mn |
| Jun 30, 2023 | 280.61 Mn |
| Mar 31, 2023 | 198.32 Mn |
| Dec 31, 2022 | 220.50 Mn |
| Sep 30, 2022 | 242.33 Mn |
| Jun 30, 2022 | 259.06 Mn |
| Mar 31, 2022 | 280.67 Mn |
| Dec 31, 2021 | 305.10 Mn |
| Sep 30, 2021 | 331.22 Mn |
API Access
Prelude Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=PRLD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "PRLD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=PRLD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();